Stocks Prognosis
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site

QuantWave Successfully Forecasts REGENERON PHARMACEUTICALS, INC. Stock Price, Achieving a Profit of 14.38%

Published on May 30, 2025
On April 4, 2025, QuantWave, an automated forecasting platform, issued a short signal for REGENERON PHARMACEUTICALS, INC.'s stock with a price of 571.74 USD. The platform accurately predicted the price movement, and on May 30, 2025, the stock reached the target price of 489.54 USD, resulting in a profit of 14.38%.
Go to REGN Page

Investor opinions & comments

To leave a comment, you need to Login or Register.

There are no comments yet. Be the first to leave one!

Other Data for REGN

Regeneron Pharmaceuticals Inc. REGN Receives Positive Opinion from European Medicines Agency

October 31, 2025

Regeneron Pharmaceuticals Inc. Continues to Impress Investors with Strong Performance

September 5, 2025

Regeneron Pharmaceuticals: Revolutionizing Healthcare with Innovative Drug Approvals

July 5, 2025

Regeneron Pharmaceuticals Inc. Continues to Impress Investors as UBS Lowers Price Target

June 27, 2025

REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 33.76% Profit Margin

June 5, 2025

REGENERON PHARMACEUTICALS, INC. Hits Forecast Price Target with a 32.0% Profit

June 5, 2025

Related Data

Regeneron Pharmaceuticals, Inc. Stock Hits Short-Term Price Target with 17.79% Profit as Forecasted by QuantWave

April 10, 2025

REGENERON PHARMACEUTICALS, INC. Stock Hits QuantWave's Price Target with 24.9% Profit

May 9, 2025

REGENERON PHARMACEUTICALS, INC. Hits Price Target Forecast with 23.04% Profit

April 8, 2025

REGENERON PHARMACEUTICALS, INC. Hits QuantWave Price Target Forecast with 17.34% Profit

April 4, 2025

REGENERON PHARMACEUTICALS, INC. Hits 30.6% Profit Target as Forecasted by QuantWave

May 30, 2025